Nicotinamide riboside + exercise

Intervention

2 papers2 findings

  • 2 independent labs in 1 country
  • Funders: National Institutes of Health and 7 more
  • Human trial2

Outcomes

2

Peak VO2

upin humans1

1 study
  1. Nicotinamide riboside + exercise increases peak VO2 in humans (0.21 L/min, 95% CI 0.05 to 0.36, padjusted=0.0299).

    “0·21 (0·05 to 0·36; padjusted=0·0299) for nicotinamide riboside and exercise in combination”

    Human trialFriedreich's ataxia12 weeksn = 66

    Safety and efficacy of individualised exercise and NAD⁺ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial

    The Lancet. Neurology17 Apr 2026

More on Peak VO2

Daytime systolic blood pressure

no changein humans1

1 study
  1. Nicotinamide riboside + exercise has no effect on daytime systolic blood pressure in humans (5.19 ± 13.2 vs - 2.71 ± 10.5 mmHg).

    “NR + Ex (mean change = 5.19 ± 13.2 mmHg) did not reduce SBP more than PL + Ex (- 2.71 ± 10.5 mmHg).”

    Human trialhypertension6 weeksn = 54

    Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial

    GeroScience7 Aug 2025

More on Daytime systolic blood pressure

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months